{"title":"巨藻补充对血脂、血糖控制和人体测量指标的影响:临床试验的系统回顾和荟萃分析","authors":"Shahla Rezaei, Saeid Doaei, Reza Tabrizi, Saeed Ghobadi, Morteza Zare, Maryam Gholamalizadeh, Zohreh Mazloom","doi":"10.1002/edm2.439","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Macro-algae products have been shown to ameliorate the metabolic disorders state. Thus, highlighting their function as supplementary therapeutic agents can be a novel strategy for clinical therapies. This systematic review and meta-analysis of clinical trials aimed to summarize the effect of macro-algae consumption on serum lipid profile, glycaemic control and anthropometric factors.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In this systematic review and meta-analysis, a comprehensive search was performed for relevant studies published up to May 2023. The Cochran's <i>Q</i> test and <i>I</i>-square (<i>I</i><sup>2</sup>) tests were used to evaluate heterogeneity across the included studies. The meta-analysis was conducted using random-effects model (DerSimonian and Laird), and weighted mean difference (WMD) was considered as the pooled effect size.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Out of 8602 papers in the initial screening, eight clinical trials with a total of 438 participants were included into this meta-analysis. The results indicated that macro-algae supplementation significantly decreased serum levels of total cholesterol (TC) (WMD = −6.7 mg/dL; 95% CI: −12.59, −0.80; item = 0.026) and low-density lipoprotein cholesterol (LDL-c) (WMD = −8.25 mg/dL; 95% CI: −15.38, −1.12; <i>p</i>-value = .023). There was an increase in level of high-density lipoprotein cholesterol (HDL-c) (WMD = 0.48 mg/dL; 95% CI: −2.05, 3.01; <i>p</i>-value = .71) which was not statistically significant. Macro-algae supplementation reduced body mass index (BMI) (WMD = −0.28 kg/m<sup>2</sup>; 95% CI: −0.96, 0.41; <i>p</i>-value = .426), weight (WMD = −0.39 kg; 95% CI: −3.6, 2.83; <i>p</i>-value = .81), waist circumference (WC) (WMD = −0.52 cm; 95% CI: −2.71, 1.66; <i>p</i>-value = .64), fasting blood sugar (FBS) (WMD = −1.95 mg/dL; 95% CI: −5.19, 1.28; <i>p</i>-value = .24) and HbA1c (WMD = −0.02%; 95% CI: −0.14, 0.09; <i>p</i>-value = .66) in intervention group.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>This meta-analysis indicated that macro-algae supplementation significantly decreased TC and LDL-c level. It can also increase HDL-c level and reduce anthropometric indices and glycaemic control factors.</p>\n </section>\n </div>","PeriodicalId":36522,"journal":{"name":"Endocrinology, Diabetes and Metabolism","volume":"6 5","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2023-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/edm2.439","citationCount":"0","resultStr":"{\"title\":\"The effects of macro-algae supplementation on serum lipid, glycaemic control and anthropometric indices: A systematic review and meta-analysis of clinical trials\",\"authors\":\"Shahla Rezaei, Saeid Doaei, Reza Tabrizi, Saeed Ghobadi, Morteza Zare, Maryam Gholamalizadeh, Zohreh Mazloom\",\"doi\":\"10.1002/edm2.439\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Macro-algae products have been shown to ameliorate the metabolic disorders state. Thus, highlighting their function as supplementary therapeutic agents can be a novel strategy for clinical therapies. This systematic review and meta-analysis of clinical trials aimed to summarize the effect of macro-algae consumption on serum lipid profile, glycaemic control and anthropometric factors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>In this systematic review and meta-analysis, a comprehensive search was performed for relevant studies published up to May 2023. The Cochran's <i>Q</i> test and <i>I</i>-square (<i>I</i><sup>2</sup>) tests were used to evaluate heterogeneity across the included studies. The meta-analysis was conducted using random-effects model (DerSimonian and Laird), and weighted mean difference (WMD) was considered as the pooled effect size.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Out of 8602 papers in the initial screening, eight clinical trials with a total of 438 participants were included into this meta-analysis. The results indicated that macro-algae supplementation significantly decreased serum levels of total cholesterol (TC) (WMD = −6.7 mg/dL; 95% CI: −12.59, −0.80; item = 0.026) and low-density lipoprotein cholesterol (LDL-c) (WMD = −8.25 mg/dL; 95% CI: −15.38, −1.12; <i>p</i>-value = .023). There was an increase in level of high-density lipoprotein cholesterol (HDL-c) (WMD = 0.48 mg/dL; 95% CI: −2.05, 3.01; <i>p</i>-value = .71) which was not statistically significant. Macro-algae supplementation reduced body mass index (BMI) (WMD = −0.28 kg/m<sup>2</sup>; 95% CI: −0.96, 0.41; <i>p</i>-value = .426), weight (WMD = −0.39 kg; 95% CI: −3.6, 2.83; <i>p</i>-value = .81), waist circumference (WC) (WMD = −0.52 cm; 95% CI: −2.71, 1.66; <i>p</i>-value = .64), fasting blood sugar (FBS) (WMD = −1.95 mg/dL; 95% CI: −5.19, 1.28; <i>p</i>-value = .24) and HbA1c (WMD = −0.02%; 95% CI: −0.14, 0.09; <i>p</i>-value = .66) in intervention group.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>This meta-analysis indicated that macro-algae supplementation significantly decreased TC and LDL-c level. It can also increase HDL-c level and reduce anthropometric indices and glycaemic control factors.</p>\\n </section>\\n </div>\",\"PeriodicalId\":36522,\"journal\":{\"name\":\"Endocrinology, Diabetes and Metabolism\",\"volume\":\"6 5\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2023-07-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/edm2.439\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Endocrinology, Diabetes and Metabolism\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/edm2.439\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrinology, Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/edm2.439","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
The effects of macro-algae supplementation on serum lipid, glycaemic control and anthropometric indices: A systematic review and meta-analysis of clinical trials
Introduction
Macro-algae products have been shown to ameliorate the metabolic disorders state. Thus, highlighting their function as supplementary therapeutic agents can be a novel strategy for clinical therapies. This systematic review and meta-analysis of clinical trials aimed to summarize the effect of macro-algae consumption on serum lipid profile, glycaemic control and anthropometric factors.
Methods
In this systematic review and meta-analysis, a comprehensive search was performed for relevant studies published up to May 2023. The Cochran's Q test and I-square (I2) tests were used to evaluate heterogeneity across the included studies. The meta-analysis was conducted using random-effects model (DerSimonian and Laird), and weighted mean difference (WMD) was considered as the pooled effect size.
Results
Out of 8602 papers in the initial screening, eight clinical trials with a total of 438 participants were included into this meta-analysis. The results indicated that macro-algae supplementation significantly decreased serum levels of total cholesterol (TC) (WMD = −6.7 mg/dL; 95% CI: −12.59, −0.80; item = 0.026) and low-density lipoprotein cholesterol (LDL-c) (WMD = −8.25 mg/dL; 95% CI: −15.38, −1.12; p-value = .023). There was an increase in level of high-density lipoprotein cholesterol (HDL-c) (WMD = 0.48 mg/dL; 95% CI: −2.05, 3.01; p-value = .71) which was not statistically significant. Macro-algae supplementation reduced body mass index (BMI) (WMD = −0.28 kg/m2; 95% CI: −0.96, 0.41; p-value = .426), weight (WMD = −0.39 kg; 95% CI: −3.6, 2.83; p-value = .81), waist circumference (WC) (WMD = −0.52 cm; 95% CI: −2.71, 1.66; p-value = .64), fasting blood sugar (FBS) (WMD = −1.95 mg/dL; 95% CI: −5.19, 1.28; p-value = .24) and HbA1c (WMD = −0.02%; 95% CI: −0.14, 0.09; p-value = .66) in intervention group.
Conclusions
This meta-analysis indicated that macro-algae supplementation significantly decreased TC and LDL-c level. It can also increase HDL-c level and reduce anthropometric indices and glycaemic control factors.